Deven Choksey prefers Sun Pharma, Cipla for fresh buying; sees upside in Indian IT
CNBC-TV18

Deven Choksey, Managing Director at DRChoksey Finserv, continues to hold
Divi's Labs and Laurus Labs but recommends waiting for corrections before
buying them. Choksey also remains positive on Indian IT companies, citing
growing AI-related order inflows, while advising investors to wait for lower
valuations in jewellery retailers such as Titan and Kalyan Jewellers.




